GeneChem is a manager of focused venture capital funds. Since 1997, we have been involved in the launching of companies and in the management of their growth and liquidity events.

GeneChem has been part of investment syndicates which included a wide breadth of marquee international investors as well as smaller local players. The team has knowledge and expertise in various fields of science including biochemistry, chemistry, immunology, oncology, virology, bacteriology, analgesia, ophthalmology and human genetics.

We have invested at the very early stages of start-ups, where hands-on management is required, and also at the later stages such as mezzanine rounds and private placements in public entities. The team's experience is broad and deep-reaching within the biotech investment sector.

1 Westmount Square, Suite 800
Montreal, Quebec
H3Z 2P9

T 514-849-7696
F 514-849-5191

Patricia Laplante, MSc Project Manager

Patricia Laplante joined the AmorChem team as Project Manager in February 2013. Patricia is a multidisciplinary scientist who has fifteen years of industry experience acquired in the pharmaceutical sector as well as in biotechnology and academic settings. She spent eleven years at AstraZeneca R&D Montreal where she was involved in the drug discovery process in the therapeutic area of pain. Prior to AstraZeneca, she worked at Procyon BioPharma, a local biotech, on a prostate cancer program and at McGill University in breast cancer research. Patricia obtained an M.Sc. (Neurology and Neurosurgery) at McGill University. During this time, she provided training and collaborated with the Western General Hospital in Edinburgh, Scotland.

T 514-849-8880
F 514-849-5191



About UsProcessPortfolioOur TeamNewsNuChemGeneChemContactFrançais

© 2018 AmorChem. All rights reserved. Developed by Grafika Designs a Montreal Web Design company.